Which has preferable earnings and valuation, BLLN or CDNA?

Billiontoone has higher earnings, but lower revenue than CareDx. CareDx is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Billiontoone $305.11M 14.96 $7.45M $0.55 180.47 CareDx $379.80M 3.19 -$21.35M -$0.16 N/A

Which has better valuation and earnings, SHC or CDNA?

Sotera Health has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sotera Health $1.16B 3.99 $77.94M $0.41 39.68 CareDx $379.80M 3.19 -$21.35M -$0.16 N/A

Is SHC or CDNA more profitable?

Sotera Health has a net margin of 9.91% compared to CareDx's net margin of -2.01%. Sotera Health's return on equity of 39.73% beat CareDx's return on equity. Company Net Margins Return on Equity Return on Assets Sotera Health 9.91% 39.73% 7.05% CareDx -2.01% -2.65% -1.96%

Does the media favor SHC or CDNA?

In the previous week, CareDx had 3 more articles in the media than Sotera Health. MarketBeat recorded 7 mentions for CareDx and 4 mentions for Sotera Health. Sotera Health's average media sentiment score of 0.93 beat CareDx's score of 0.68 indicating that Sotera Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CareDx 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, CDNA or RDNT?

RadNet has higher revenue and earnings than CareDx. RadNet is trading at a lower price-to-earnings ratio than CareDx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CareDx $379.80M 3.19 -$21.35M -$0.16 N/A RadNet $2.04B 2.24 -$18.65M -$0.18 N/A

Is CDNA or RDNT more profitable?

RadNet has a net margin of -0.66% compared to CareDx's net margin of -2.01%. RadNet's return on equity of 2.77% beat CareDx's return on equity. Company Net Margins Return on Equity Return on Assets CareDx -2.01% -2.65% -1.96% RadNet -0.66% 2.77% 0.97%

Does the media refer more to CDNA or RDNT?

In the previous week, RadNet had 1 more articles in the media than CareDx. MarketBeat recorded 8 mentions for RadNet and 7 mentions for CareDx. CareDx's average media sentiment score of 0.68 beat RadNet's score of 0.21 indicating that CareDx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CareDx 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 1 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings & valuation, VCYT or CDNA?

Veracyte has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Veracyte $517.15M 7.43 $66.35M $1.09 44.19 CareDx $379.80M 3.19 -$21.35M -$0.16 N/A

Is VCYT or CDNA more profitable?

Veracyte has a net margin of 16.25% compared to CareDx's net margin of -2.01%. Veracyte's return on equity of 9.07% beat CareDx's return on equity. Company Net Margins Return on Equity Return on Assets Veracyte 16.25% 9.07% 8.38% CareDx -2.01% -2.65% -1.96%

Does the media favor VCYT or CDNA?

In the previous week, Veracyte had 11 more articles in the media than CareDx. MarketBeat recorded 18 mentions for Veracyte and 7 mentions for CareDx. CareDx's average media sentiment score of 0.68 beat Veracyte's score of 0.48 indicating that CareDx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veracyte 9 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral CareDx 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, CDNA or OPCH?

Option Care Health has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CareDx $379.80M 3.19 -$21.35M -$0.16 N/A Option Care Health $5.65B 0.59 $207.59M $1.29 16.57

Does the media refer more to CDNA or OPCH?

In the previous week, Option Care Health had 2 more articles in the media than CareDx. MarketBeat recorded 9 mentions for Option Care Health and 7 mentions for CareDx. Option Care Health's average media sentiment score of 1.37 beat CareDx's score of 0.68 indicating that Option Care Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CareDx 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Option Care Health 3 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

CareDx (CDNA) Competitors

$23.46 +0.71 (+3.12%)

Closing price 04:00 PM Eastern

Extended Trading

$23.46 0.00 (0.00%)

As of 06:46 PM Eastern

Compare

CDNA vs. BLLN, SHC, RDNT, VCYT, and OPCH

Should you buy CareDx stock or one of its competitors? MarketBeat compares CareDx with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CareDx include Billiontoone (BLLN), Sotera Health (SHC), RadNet (RDNT), Veracyte (VCYT), and Option Care Health (OPCH). These companies are all part of the "healthcare" industry.

How does CareDx compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and CareDx (NASDAQ:CDNA) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

Billiontoone presently has a consensus target price of $125.29, suggesting a potential upside of 26.22%. CareDx has a consensus target price of $25.00, suggesting a potential upside of 6.56%. Given Billiontoone's stronger consensus rating and higher probable upside, equities research analysts clearly believe Billiontoone is more favorable than CareDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Billiontoone has higher earnings, but lower revenue than CareDx. CareDx is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	14.96	$7.45M	$0.55	180.47
CareDx	$379.80M	3.19	-$21.35M	-$0.16	N/A

Billiontoone has a net margin of 0.00% compared to CareDx's net margin of -2.01%. Billiontoone's return on equity of 0.00% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
CareDx	-2.01%	-2.65%	-1.96%

In the previous week, CareDx had 6 more articles in the media than Billiontoone. MarketBeat recorded 7 mentions for CareDx and 1 mentions for Billiontoone. Billiontoone's average media sentiment score of 1.52 beat CareDx's score of 0.68 indicating that Billiontoone is being referred to more favorably in the media.

Company	Overall Sentiment
Billiontoone	Very Positive
CareDx	Positive

Summary

Billiontoone beats CareDx on 11 of the 13 factors compared between the two stocks.

How does CareDx compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and CareDx (NASDAQ:CDNA) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, media sentiment, valuation and risk.

Sotera Health has a beta of 1.79, indicating that its stock price is 79% more volatile than the broader market. Comparatively, CareDx has a beta of 2.49, indicating that its stock price is 149% more volatile than the broader market.

91.0% of Sotera Health shares are held by institutional investors. 15.4% of Sotera Health shares are held by company insiders. Comparatively, 2.4% of CareDx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Sotera Health has a net margin of 9.91% compared to CareDx's net margin of -2.01%. Sotera Health's return on equity of 39.73% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
CareDx	-2.01%	-2.65%	-1.96%

Sotera Health presently has a consensus target price of $20.29, indicating a potential upside of 24.68%. CareDx has a consensus target price of $25.00, indicating a potential upside of 6.56%. Given Sotera Health's stronger consensus rating and higher possible upside, research analysts clearly believe Sotera Health is more favorable than CareDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Sotera Health has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	3.99	$77.94M	$0.41	39.68
CareDx	$379.80M	3.19	-$21.35M	-$0.16	N/A

In the previous week, CareDx had 3 more articles in the media than Sotera Health. MarketBeat recorded 7 mentions for CareDx and 4 mentions for Sotera Health. Sotera Health's average media sentiment score of 0.93 beat CareDx's score of 0.68 indicating that Sotera Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CareDx	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Sotera Health beats CareDx on 14 of the 16 factors compared between the two stocks.

How does CareDx compare to RadNet?

CareDx (NASDAQ:CDNA) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, profitability, risk, dividends, earnings and analyst recommendations.

RadNet has a net margin of -0.66% compared to CareDx's net margin of -2.01%. RadNet's return on equity of 2.77% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareDx	-2.01%	-2.65%	-1.96%
RadNet	-0.66%	2.77%	0.97%

77.9% of RadNet shares are owned by institutional investors. 2.4% of CareDx shares are owned by insiders. Comparatively, 5.6% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

RadNet has higher revenue and earnings than CareDx. RadNet is trading at a lower price-to-earnings ratio than CareDx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareDx	$379.80M	3.19	-$21.35M	-$0.16	N/A
RadNet	$2.04B	2.24	-$18.65M	-$0.18	N/A

CareDx has a beta of 2.49, suggesting that its share price is 149% more volatile than the broader market. Comparatively, RadNet has a beta of 1.41, suggesting that its share price is 41% more volatile than the broader market.

In the previous week, RadNet had 1 more articles in the media than CareDx. MarketBeat recorded 8 mentions for RadNet and 7 mentions for CareDx. CareDx's average media sentiment score of 0.68 beat RadNet's score of 0.21 indicating that CareDx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CareDx	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	1 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

CareDx presently has a consensus target price of $25.00, indicating a potential upside of 6.56%. RadNet has a consensus target price of $87.43, indicating a potential upside of 50.32%. Given RadNet's stronger consensus rating and higher probable upside, analysts clearly believe RadNet is more favorable than CareDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90

Summary

RadNet beats CareDx on 12 of the 17 factors compared between the two stocks.

How does CareDx compare to Veracyte?

Veracyte (NASDAQ:VCYT) and CareDx (NASDAQ:CDNA) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

Veracyte presently has a consensus price target of $47.57, indicating a potential downside of 1.24%. CareDx has a consensus price target of $25.00, indicating a potential upside of 6.56%. Given CareDx's higher probable upside, analysts clearly believe CareDx is more favorable than Veracyte.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veracyte	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.56
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Veracyte has a net margin of 16.25% compared to CareDx's net margin of -2.01%. Veracyte's return on equity of 9.07% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veracyte	16.25%	9.07%	8.38%
CareDx	-2.01%	-2.65%	-1.96%

In the previous week, Veracyte had 11 more articles in the media than CareDx. MarketBeat recorded 18 mentions for Veracyte and 7 mentions for CareDx. CareDx's average media sentiment score of 0.68 beat Veracyte's score of 0.48 indicating that CareDx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Veracyte	9 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
CareDx	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Veracyte has a beta of 1.98, suggesting that its share price is 98% more volatile than the broader market. Comparatively, CareDx has a beta of 2.49, suggesting that its share price is 149% more volatile than the broader market.

Veracyte has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veracyte	$517.15M	7.43	$66.35M	$1.09	44.19
CareDx	$379.80M	3.19	-$21.35M	-$0.16	N/A

Summary

Veracyte beats CareDx on 12 of the 15 factors compared between the two stocks.

How does CareDx compare to Option Care Health?

CareDx (NASDAQ:CDNA) and Option Care Health (NASDAQ:OPCH) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, earnings, dividends, analyst recommendations and institutional ownership.

In the previous week, Option Care Health had 2 more articles in the media than CareDx. MarketBeat recorded 9 mentions for Option Care Health and 7 mentions for CareDx. Option Care Health's average media sentiment score of 1.37 beat CareDx's score of 0.68 indicating that Option Care Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CareDx	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Option Care Health	3 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

98.1% of Option Care Health shares are held by institutional investors. 2.4% of CareDx shares are held by company insiders. Comparatively, 1.7% of Option Care Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

CareDx presently has a consensus price target of $25.00, suggesting a potential upside of 6.56%. Option Care Health has a consensus price target of $30.54, suggesting a potential upside of 42.84%. Given Option Care Health's stronger consensus rating and higher possible upside, analysts plainly believe Option Care Health is more favorable than CareDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Option Care Health	1 Sell rating(s)	4 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.64

CareDx has a beta of 2.49, suggesting that its share price is 149% more volatile than the broader market. Comparatively, Option Care Health has a beta of 0.67, suggesting that its share price is 33% less volatile than the broader market.

Option Care Health has a net margin of 3.64% compared to CareDx's net margin of -2.01%. Option Care Health's return on equity of 18.17% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareDx	-2.01%	-2.65%	-1.96%
Option Care Health	3.64%	18.17%	7.16%

Option Care Health has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareDx	$379.80M	3.19	-$21.35M	-$0.16	N/A
Option Care Health	$5.65B	0.59	$207.59M	$1.29	16.57

Summary

Option Care Health beats CareDx on 14 of the 17 factors compared between the two stocks.

Get CareDx News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CDNA vs. The Competition

Export

Metric	CareDx	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.21B	$8.87B	$6.43B	$11.71B
Dividend Yield	N/A	1.76%	2.67%	5.55%
P/E Ratio	-146.63	24.39	24.49	23.62
Price / Sales	3.19	18.41	500.49	105.27
Price / Cash	3,369.98	87.37	42.36	56.09
Price / Book	3.98	5.45	10.43	6.70
Net Income	-$21.35M	$179.69M	$3.56B	$337.26M
7 Day Performance	5.15%	0.42%	-1.38%	-1.41%
1 Month Performance	7.52%	5.98%	0.86%	1.15%
1 Year Performance	18.19%	0.73%	19.43%	22.61%

CareDx Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CDNA CareDx	1.833 of 5 stars	$23.46 +3.1%	$25.00 +6.6%	+15.4%	$1.21B	$379.80M	N/A	740	News Coverage Insider Trade
BLLN Billiontoone	4.5409 of 5 stars	$91.12 -8.0%	$125.29 +37.5%	N/A	$4.55B	$354.54M	165.67	620	Positive News Gap Down
SHC Sotera Health	3.8042 of 5 stars	$15.54 -0.6%	$20.33 +30.8%	+33.7%	$4.46B	$1.16B	37.90	3,000	Positive News
RDNT RadNet	3.1427 of 5 stars	$52.89 -4.8%	$87.43 +65.3%	-4.9%	$4.37B	$2.04B	N/A	11,264
VCYT Veracyte	2.1986 of 5 stars	$48.18 +4.0%	$46.33 -3.8%	+76.8%	$3.70B	$541.74M	44.20	790

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CDNA) was last updated on 6/10/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CareDx (CDNA) Competitors